A low prostate-specific antigen (PSA) threshold for triggering biopsy has increased the number of patients with prostate cancer (PCa) and lymph node (LN) metastasis [LN(+)] confirmed by postoperative pathology, despite being LN(−) by preoperative imaging (1). The gene discussed is KLK3; the disease is prostate cancer.